Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Leonardo Fantoni"'
Autor:
Veronica Giusti, Giacomo Miserocchi, Giulia Sbanchi, Micaela Pannella, Claudia Maria Hattinger, Marilena Cesari, Leonardo Fantoni, Ania Naila Guerrieri, Chiara Bellotti, Alessandro De Vita, Chiara Spadazzi, Davide Maria Donati, Monica Torsello, Enrico Lucarelli, Toni Ibrahim, Laura Mercatali
Publikováno v:
Biomedicines, Vol 12, Iss 8, p 1921 (2024)
Musculoskeletal sarcomas pose major challenges to researchers and clinicians due to their rarity and heterogeneity. Xenografting human cells or tumor fragments in rodents is a mainstay for the generation of cancer models and for the preclinical trial
Externí odkaz:
https://doaj.org/article/b62b69d1957b47d4ae7db370d746fddf
Autor:
Chiara Casotti, Claudia Maria Hattinger, Maria Pia Patrizio, Silvia Luppi, Leonardo Fantoni, Michela Pasello, Katia Scotlandi, Toni Ibrahim, Massimo Serra
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Methotrexate (MTX) is one of the most important drugs included in the first-line protocols to treat high-grade osteosarcoma (HGOS). Although several polymorphisms have been reported to be associated with drug response or MTX-related tox
Externí odkaz:
https://doaj.org/article/8139d9c37b0e48caa53e1ce404be4871
Autor:
Massimo Serra, Claudia Maria Hattinger, Michela Pasello, Chiara Casotti, Leonardo Fantoni, Chiara Riganti, Maria Cristina Manara
Publikováno v:
Cells, Vol 10, Iss 9, p 2461 (2021)
The ATP-binding cassette (ABC) transporter superfamily consists of several proteins with a wide repertoire of functions. Under physiological conditions, ABC transporters are involved in cellular trafficking of hormones, lipids, ions, xenobiotics, and
Externí odkaz:
https://doaj.org/article/acfb63b2d0124ae78b77743acfe55850
Autor:
Claudia Maria Hattinger, Iris Chiara Salaroglio, Leonardo Fantoni, Martina Godel, Chiara Casotti, Joanna Kopecka, Katia Scotlandi, Toni Ibrahim, Chiara Riganti, Massimo Serra
Improving the prognosis and cure rate of HGOSs (high-grade osteosarcomas) is an absolute need. Immune-based treatment approaches have been increasingly taken into consideration, in particular for metastatic, relapsed and refractory HGOS patients, to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f2db4f23412d5f08f8123bcbf84bfb3
https://hdl.handle.net/2318/1885662
https://hdl.handle.net/2318/1885662
Autor:
Claudia Maria Hattinger, Chiara Casotti, Maria Pia Patrizio, Silvia Luppi, Leonardo Fantoni, Katia Scotlandi, Toni Ibrahim, Massimo Serra
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 19; Pages: 11787
Cisplatin (CDDP) is a drug for high-grade osteosarcoma (HGOS) treatment. Several germline pharmacogenetic studies have revealed associations between single nucleotide polymorphisms (SNPs) and CDDP-based therapy response or CDDP-related toxicity in pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59ed0fa61bdfd88b7093c47f407bf5cd
Autor:
Chiara Casotti, Leonardo Fantoni, Chiara Riganti, Claudia Maria Hattinger, Massimo Serra, Michela Pasello, Maria Cristina Manara
Publikováno v:
Cells
Cells, Vol 10, Iss 2461, p 2461 (2021)
Cells, Vol 10, Iss 2461, p 2461 (2021)
The ATP-binding cassette (ABC) transporter superfamily consists of several proteins with a wide repertoire of functions. Under physiological conditions, ABC transporters are involved in cellular trafficking of hormones, lipids, ions, xenobiotics, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1920a5d82984bc6ebccbd279e9feb92
http://europepmc.org/articles/PMC8467338
http://europepmc.org/articles/PMC8467338
Autor:
Leonardo Fantoni, Massimo Serra, Claudia Maria Hattinger, Maria Pia Patrizio, Chiara Riganti, Chiara Casotti
Publikováno v:
Cancers
Cancers, Vol 13, Iss 2878, p 2878 (2021)
Cancers, Vol 13, Iss 2878, p 2878 (2021)
Simple Summary Despite the adoption of aggressive, multimodal treatment schedules, the cure rate of high-grade osteosarcoma (HGOS) has not significantly improved in the last 30 years. The most relevant problem preventing improvement in HGOS prognosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96d835add4f9c2f19107ff8c69ce649a
https://doi.org/10.3390/cancers13122878
https://doi.org/10.3390/cancers13122878